Caray, Sayrel J.

HRN: 26-83-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
TENOFOVIR DISOPROXIL FUMARATE 300MG TAB
06/20/2025
06/27/2025
PO
300mg
OD
Hepatitis B Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: